Skip to main content
Premium Trial:

Request an Annual Quote

GenMark Enters Into $65M Loan and Security Agreement

NEW YORK (GenomeWeb) – GenMark Diagnostics said on Wednesday that it entered into a loan and security agreement on Feb. 1 through which Solar Capital is providing it with up to $65 million in a series of term loans.

In a filing with the US Securities and Exchange Commission, GenMark said that under the terms of the agreement, it had an option to borrow $50 million on Feb. 1 as part of a Tranche 1 Loan. It can borrow an additional $15 million no later than Dec. 31, 2019, should GenMark achieve a designated threshold amount of product revenues on a trailing six-month basis.

In the SEC filing, GenMark said that on Feb. 1, it used about $38.8 million of the Tranche 1 Loan proceeds to repay all outstanding principal, interest, related fees, and other obligations under its existing loan and security agreement with Solar Senior Capital, dated Jan. 12, 2015.

Under the agreement, the term loans will accrue interest at a floating per annum rate in effect from time-to-time equal to the greater of 2.51 percent or the one-month LIBOR rate in effect as of the applicable payment date, plus 5.90 percent per annum.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.